HEADER TRANSCRIPTION 22-JUL-19 6SBO TITLE ESTROGEN RECEPTOR MUTANT L536S COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 5 GROUP A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS RECEPTOR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR F.VALLEE,V.STEIER,A.RAK REVDAT 3 15-MAY-24 6SBO 1 REMARK REVDAT 2 05-FEB-20 6SBO 1 JRNL REVDAT 1 27-NOV-19 6SBO 0 JRNL AUTH Y.EL-AHMAD,M.TABART,F.HALLEY,V.CERTAL,F.THOMPSON, JRNL AUTH 2 B.FILOCHE-ROMME,F.GRUSS-LELEU,C.MULLER,M.BROLLO,L.FABIEN, JRNL AUTH 3 V.LOYAU,L.BERTIN,P.RICHEPIN,F.PILORGE,P.DESMAZEAU, JRNL AUTH 4 C.GIRARDET,S.BECCARI,A.LOUBOUTIN,G.LEBOURG,J.LE-ROUX, JRNL AUTH 5 C.TERRIER,F.VALLEE,V.STEIER,M.MATHIEU,A.RAK,P.Y.ABECASSIS, JRNL AUTH 6 P.VICAT,T.BENARD,M.BOUABOULA,F.SUN,M.SHOMALI,A.HEBERT, JRNL AUTH 7 M.LEVIT,H.CHENG,A.COURJAUD,C.GINESTY,C.PERRAULT, JRNL AUTH 8 C.GARCIA-ECHEVERRIA,G.MCCORT,L.SCHIO JRNL TITL DISCOVERY OF JRNL TITL 2 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL) JRNL TITL 3 PYRROLIDIN-3-YL]OXYPHENYL]-8, JRNL TITL 4 9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC ACID (SAR439859), JRNL TITL 5 A POTENT AND SELECTIVE ESTROGEN RECEPTOR DEGRADER (SERD) FOR JRNL TITL 6 THE TREATMENT OF ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER. JRNL REF J.MED.CHEM. V. 63 512 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 31721572 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01293 REMARK 2 REMARK 2 RESOLUTION. 1.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 69.8 REMARK 3 NUMBER OF REFLECTIONS : 57289 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2894 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.48 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.58 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 8.12 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1146 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2157 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1081 REMARK 3 BIN R VALUE (WORKING SET) : 0.2161 REMARK 3 BIN FREE R VALUE : 0.2084 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.67 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 65 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3811 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 350 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.57310 REMARK 3 B22 (A**2) : 0.60620 REMARK 3 B33 (A**2) : -0.03320 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.15690 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.220 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.106 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.098 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.104 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.097 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4088 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5547 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1488 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 732 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4088 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 520 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5327 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.82 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.65 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6SBO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-JUL-19. REMARK 100 THE DEPOSITION ID IS D_1292103433. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978570 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57289 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.480 REMARK 200 RESOLUTION RANGE LOW (A) : 49.830 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.5 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG4000, NACACODYLATE 0.1M PH 6.5, REMARK 280 MGCL2 200MM, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 50.71500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.85500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 50.71500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.85500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 295 REMARK 465 ALA A 296 REMARK 465 MET A 297 REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 ARG A 300 REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 TYR A 331 REMARK 465 ASP A 332 REMARK 465 PRO A 333 REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 PRO A 336 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 GLY B 295 REMARK 465 ALA B 296 REMARK 465 MET B 297 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 ARG B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 306 CG CD1 CD2 REMARK 470 ARG A 477 CZ NH1 NH2 REMARK 470 LYS A 531 CG CD CE NZ REMARK 470 LEU B 306 CG CD1 CD2 REMARK 470 GLU B 419 CG CD OE1 OE2 REMARK 470 ARG B 477 CZ NH1 NH2 REMARK 470 HIS B 547 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 549 CG CD1 CD2 REMARK 470 HIS B 550 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 462 -27.28 66.29 REMARK 500 LYS A 529 78.49 45.37 REMARK 500 PHE B 337 -33.49 68.69 REMARK 500 LEU B 549 43.68 -106.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 PHE B 337 10.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L5B A 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L5B B 4000 DBREF 6SBO A 297 554 UNP P03372 ESR1_HUMAN 124 381 DBREF 6SBO B 297 554 UNP P03372 ESR1_HUMAN 124 381 SEQADV 6SBO GLY A 295 UNP P03372 EXPRESSION TAG SEQADV 6SBO ALA A 296 UNP P03372 EXPRESSION TAG SEQADV 6SBO SER A 536 UNP P03372 LEU 363 ENGINEERED MUTATION SEQADV 6SBO GLY B 295 UNP P03372 EXPRESSION TAG SEQADV 6SBO ALA B 296 UNP P03372 EXPRESSION TAG SEQADV 6SBO SER B 536 UNP P03372 LEU 363 ENGINEERED MUTATION SEQRES 1 A 260 GLY ALA MET ILE LYS ARG SER LYS LYS ASN SER LEU ALA SEQRES 2 A 260 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 3 A 260 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 4 A 260 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 5 A 260 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 6 A 260 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 7 A 260 HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU SEQRES 8 A 260 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 9 A 260 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 10 A 260 ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL GLU ILE SEQRES 11 A 260 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 12 A 260 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 13 A 260 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 14 A 260 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 15 A 260 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 16 A 260 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 17 A 260 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 18 A 260 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 19 A 260 LYS CYS LYS ASN VAL VAL PRO SER TYR ASP LEU LEU LEU SEQRES 20 A 260 GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 B 260 GLY ALA MET ILE LYS ARG SER LYS LYS ASN SER LEU ALA SEQRES 2 B 260 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 3 B 260 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 4 B 260 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 5 B 260 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 6 B 260 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 7 B 260 HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU SEQRES 8 B 260 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 9 B 260 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 10 B 260 ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL GLU ILE SEQRES 11 B 260 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 12 B 260 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 13 B 260 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 14 B 260 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 15 B 260 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 16 B 260 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 17 B 260 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 18 B 260 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 19 B 260 LYS CYS LYS ASN VAL VAL PRO SER TYR ASP LEU LEU LEU SEQRES 20 B 260 GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER HET L5B A4000 38 HET L5B B4000 38 HETNAM L5B 6-(2,4-DICHLOROPHENYL)-5-[4-[(3~{S})-1-(3- HETNAM 2 L5B FLUORANYLPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9- HETNAM 3 L5B DIHYDRO-7~{H}-BENZO[7]ANNULENE-2-CARBOXYLIC ACID FORMUL 3 L5B 2(C31 H30 CL2 F N O3) FORMUL 5 HOH *350(H2 O) HELIX 1 AA1 LEU A 306 LEU A 310 5 5 HELIX 2 AA2 THR A 311 GLU A 323 1 13 HELIX 3 AA3 SER A 338 VAL A 364 1 27 HELIX 4 AA4 GLY A 366 LEU A 370 5 5 HELIX 5 AA5 THR A 371 MET A 396 1 26 HELIX 6 AA6 ASN A 413 VAL A 418 5 6 HELIX 7 AA7 GLY A 420 ASN A 439 1 20 HELIX 8 AA8 GLN A 441 SER A 456 1 16 HELIX 9 AA9 GLY A 457 PHE A 461 5 5 HELIX 10 AB1 THR A 465 ALA A 493 1 29 HELIX 11 AB2 THR A 496 MET A 528 1 33 HELIX 12 AB3 SER A 536 ASP A 545 1 10 HELIX 13 AB4 LEU B 306 LEU B 310 5 5 HELIX 14 AB5 THR B 311 GLU B 323 1 13 HELIX 15 AB6 SER B 341 ARG B 363 1 23 HELIX 16 AB7 GLY B 366 LEU B 370 5 5 HELIX 17 AB8 THR B 371 MET B 396 1 26 HELIX 18 AB9 ASN B 413 VAL B 418 5 6 HELIX 19 AC1 GLY B 420 ASN B 439 1 20 HELIX 20 AC2 GLN B 441 SER B 456 1 16 HELIX 21 AC3 GLY B 457 PHE B 461 5 5 HELIX 22 AC4 LEU B 466 ALA B 493 1 28 HELIX 23 AC5 THR B 496 MET B 528 1 33 HELIX 24 AC6 SER B 536 ASP B 545 1 10 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 SITE 1 AC1 19 MET A 343 LEU A 346 THR A 347 LEU A 349 SITE 2 AC1 19 ALA A 350 ASP A 351 GLU A 353 TRP A 383 SITE 3 AC1 19 LEU A 387 ARG A 394 MET A 421 GLY A 521 SITE 4 AC1 19 HIS A 524 LEU A 525 VAL A 533 VAL A 534 SITE 5 AC1 19 PRO A 535 LEU A 539 HOH A4118 SITE 1 AC2 22 MET B 343 LEU B 346 THR B 347 LEU B 349 SITE 2 AC2 22 ALA B 350 ASP B 351 GLU B 353 LEU B 354 SITE 3 AC2 22 LEU B 387 ARG B 394 MET B 421 ILE B 424 SITE 4 AC2 22 GLY B 521 HIS B 524 LEU B 525 MET B 528 SITE 5 AC2 22 ASN B 532 VAL B 533 VAL B 534 PRO B 535 SITE 6 AC2 22 LEU B 539 HOH B4120 CRYST1 101.430 57.710 87.800 90.00 103.13 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009859 0.000000 0.002300 0.00000 SCALE2 0.000000 0.017328 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011695 0.00000